Description:

Center for Dissemination and Implementation At Stanford (C-DIAS)

Prevention Science & Methodology Group (PSMG) Virtual Grand Rounds

Tuesday, April 8, 2025

12:00 – 1:30 PM CT

Andrea Jakubowski, MD, MS
Montefoire

Low Threshold Buprenorphine: What do we know and where do we go from here?

Over two decades into the opioid overdose crisis, buprenorphine remains underutilized and inaccessible to many people with opioid use disorder. Improving accessibility and utilization requires attention to where treatment is offered and how patients are treated once they enter care. In this presentation, Dr. Jakubowski will describe: 1) principles of low-threshold buprenorphine; 2) clinical and implementation data on syringes services program (SSP)-based buprenorphine programs; 3) early findings from Dr. Jakubowski’s NIDA K23 examining implementation of long-acting injectable buprenorphine in SSP and primary care clinics; 4) description and rationale of CTN-0155: Low-Threshold Buprenorphine Treatment at Syringe Services Programs: A Type I Hybrid Effectiveness-implementation Trial.

Please join our PSMG listserv to attend live at https://cepim.northwestern.edu/psmg-membership or you may view any of our past presentations on our archive which are open to all https://cepim.northwestern.edu/psmg-archive